Additionally, due to the small number of cases in the MG group, the differences observed between the distribution of HLA-A, HLA-B or HLA-DRB1 haplotypes between MG and control subjects should be interpreted with caution. This evidence concerns the gene HLA-B and myasthenia gravis.